If I’m not mistaken, the N of each arm, 350mg and 700mg was pretty small. And the genomic haplotype in the 700mg arm was leaning towards delta 32 deletion by hereditary mutation (single allele v double allele, I can’t say - although Ohm responded publicly to me with an explanation a month or two ago that y’all can search for).

The next studies we do in Nash/Mash should clarify how dosing works and what qualifying haplotypes would be appropriate for LL. It’s not black or white, on or off, there is a lot of grey area. IMO.